Locations:
SearchAdvertisement
Seven-gene biosignature becomes first effective means to reduce over- and under-treatment with radiation therapy
Rare cancer presents as unresolved changes of the nipple
Retrospective study involves 18 years of follow-up and shows low risk of local recurrence.
Use of tool can change recommendation to add or omit radiation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Tumor genomics offer clues for identifying high risk of relapse
Multi-center study indicates benefit is associated with risk stratification and the utilization of radiation therapy
Novel assay identifies women most likely to benefit
Review assesses current data regarding treatment options
Advertisement
Advertisement